Drug recall · November 2, 2022
8.4% Sodium Bicarbonate Injection recall
Why: Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20 vials, Rx Only, Mfd for: Civica, Inc. Lehi, Utah 84043, Mfd by: Exela Pharma Sciences, LLC, Lenoir, NC 28645, Carton NDC 72572-740-20, vial NDC 72572-740-1.
- Lots / codes
Lot #: P0001497 Exp. 12/2023; P0001600 Exp. 02/2024; P0001663 Exp. 03/2024
- Quantity
- 148,920
- Company
- Exela Pharma Sciences LLC, Lenoir, NC
- Distribution
- Nationwide within the United States
- Initiated
- October 4, 2022 · Voluntary: Firm initiated
- Classified
- October 27, 2022
- Reported
- November 2, 2022
- Ended
- October 10, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Sodium bicarbonate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.